Beilstein Arch. 2022, 202272. https://doi.org/10.3762/bxiv.2022.72.v1
Published 16 Sep 2022
Rhodium-catalyzed intramolecular reductive aldol-type cyclization was described to give β-hydroxylactones with high diastereoselectivities. This cyclization gave syn- or anti-form β-hydroxylactones selectively by changing the solvent. Furthermore, the synthesis of a chiral necic acid lactone was also described which is a part of structural component of pyrrolizidine alkaloid monocrotaline that is used for the preparation of pulmonary hypertension pathological model in rats.
Keywords: intramolecular reductive aldol cyclization; β-hydroxylactone; rhodium catalyst; necic acid lactone
|Format: DOCX||Size: 29.5 MB||Download|
When a peer-reviewed version of this preprint is available, this information will be updated in the information box above. If no peer-reviewed version is available, please cite this preprint using the following information:
Isoda, M.; Sato, K.; Kameda, K.; Wakabayashi, K.; Sato, R.; Minami, H.; Karuo, Y.; Tarui, A.; Kawai, K.; Omote, M. Beilstein Arch. 2022, 202272. doi:10.3762/bxiv.2022.72.v1
|Download RIS (Reference Manager)||Download BIB (BIBTEX)|
© 2022 Isoda et al.; licensee Beilstein-Institut.
This is an open access work licensed under the terms of the Beilstein-Institut Open Access License Agreement (https://www.beilstein-archives.org/xiv/terms), which is identical to the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0). The reuse of material under this license requires that the author(s), source and license are credited. Third-party material in this work could be subject to other licenses (typically indicated in the credit line), and in this case, users are required to obtain permission from the license holder to reuse the material.